"id","description","instanceType","name","uuid:ID","label","text"
"Objective_1","Main objective","Objective","OBJ1","b34a6748-ffc5-4f6e-a65e-03532d16805c","","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg])."
"Objective_2","Safety","Objective","OBJ2","1e8921e8-6b92-4faf-8f41-d7b7f6b3099d","","To document the safety profile of the xanomeline TTS."
"Objective_3","Behaviour","Objective","OBJ3","3fe373c4-c478-48e8-9a6d-4c9791257a52","","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas."
